Trial Profile
Effects of Recombinant Human Erythropoietin (rHuEPO) in patients with multiple myeloma
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 13 Nov 2014
Price :
$35
*
At a glance
- Drugs Recombinant erythropoietin (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 13 Nov 2014 New trial record